Ticker Sage

Insider digest · PFE

Pfizer insider filings, Sep 29, 2026

Pfizer insiders filed 6 routine Form 4 reports on Sep 29, 2026: awards. None of them was a purchase or a sale in the market. This page groups them in one place; each row links to the filing note, and each number links to the Form 4 itself.

What the codes mean: how to read a Form 4 · stock-based compensation.

Stock awards and grants

Shares or units the company granted as pay. No shares were bought or sold in the market. Total for the day: 8,894 shares or units, worth about $255,000 at the prices reported.

PersonCodeSecuritySharesPriceValueHeld after
Cyrus Taraporevala · directorAPhantom Stock Units1,307.987$28.67$37,50038,806
James C. Smith · directorAPhantom Stock Units1,569.585$28.67$45,000187,210
James Quincey · directorAPhantom Stock Units1,351.587$28.67$38,75090,671
Shantanu Narayen · directorAPhantom Stock Units1,743.983$28.67$50,000205,649
Joseph Echevarria · directorAPhantom Stock Units1,613.185$28.67$46,250169,739
Mortimer J. Buckley · directorAPhantom Stock Units1,307.987$28.67$37,50028,040

The filings

Pfizer company file → · All Pfizer filings notes

Disclosures

Editor holdings in PFE
The editor holds no position in Pfizer (PFE). As of Nov 11, 2026.
Compensation
Nobody paid for this page. No affiliate links.

A summary of public filings for general education, the same for every reader. Not a recommendation to buy, sell or hold PFE.